KRISTEN WOLF: Open Payments
NPI 1003896689 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 45 payments from 18 companies in 2025. Trend: 2023 $1,244 · 2024 $1,259 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $144 |
| Amgen Inc. | 9 | $136 |
| Janssen Biotech, Inc. | 5 | $101 |
| Novo Nordisk Inc | 5 | $98 |
| Kestra Medical Technology Services, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
Products named: CREON, TREMFYA, Wegovy, OTEZLA, Assure WCD, LEQVIO, ZENPEP, REPATHA.
Industry payments across KS — which companies pay providers there.
